These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14522542)

  • 21. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.
    Boman K; Jansson JH; Nilsson T; Swedberg K; Cleland JG; Poole-Wilson P
    Thromb Res; 2010 Feb; 125(2):e46-50. PubMed ID: 19762071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Numerous indications in cardiology. Beta receptor blockers can never be overlooked].
    MMW Fortschr Med; 2005 May; 147(18):57. PubMed ID: 15934594
    [No Abstract]   [Full Text] [Related]  

  • 23. Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure).
    Goldstein S; Deedwania P; Gottlieb S; Wikstrand J;
    Am J Cardiol; 2003 Aug; 92(4):478-80. PubMed ID: 12914886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability of beta-blockers in heart failure: reassurance needed, reassurance provided.
    Krum H
    Ital Heart J; 2003 Apr; 4(4):225-7. PubMed ID: 12784773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
    Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
    Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial.
    Greenberg B
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S10-7. PubMed ID: 15184835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.
    McBride BF; White CM
    J Clin Pharmacol; 2005 Jan; 45(1):6-24. PubMed ID: 15601801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.
    Batty JA; Hall AS; White HL; Wikstrand J; de Boer RA; van Veldhuisen DJ; van der Harst P; Waagstein F; Hjalmarson Å; Kjekshus J; Balmforth AJ;
    Clin Pharmacol Ther; 2014 Mar; 95(3):321-30. PubMed ID: 24193112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to change the paradigm? Which paradigm?
    Kempen PM
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1099-100. PubMed ID: 19694620
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.
    ; Devereaux PJ; Yang H; Yusuf S; Guyatt G; Leslie K; Villar JC; Xavier D; Chrolavicius S; Greenspan L; Pogue J; Pais P; Liu L; Xu S; Málaga G; Avezum A; Chan M; Montori VM; Jacka M; Choi P
    Lancet; 2008 May; 371(9627):1839-47. PubMed ID: 18479744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of beta-blockers for heart failure: proven in 1999.
    Sharpe N
    Lancet; 1999 Jun; 353(9169):1988-9. PubMed ID: 10376609
    [No Abstract]   [Full Text] [Related]  

  • 34. Sleep quality in patients with hypertension: additional negative effect of drug therapy.
    Yontar OC; Erdem A; Yilmaz MB
    Sleep Med; 2009 Dec; 10(10):1168; author reply 1168-9. PubMed ID: 19467925
    [No Abstract]   [Full Text] [Related]  

  • 35. [beta-Adrenoblockers in cardiology: metoprolol succinate].
    Zateĭshchikov DA; Dankovtseva EN
    Kardiologiia; 2007; 47(8):87-92. PubMed ID: 18260921
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 37. [Does the use of metoprolol-succinate in patients with chronic heart failure lead to a higher efficacy in treatment without causing additional costs?].
    Sonntag F; Schöffski O; Hass B
    MMW Fortschr Med; 2005 Jun; 147(24):39. PubMed ID: 16001533
    [No Abstract]   [Full Text] [Related]  

  • 38. Are there clinically important differences between beta-blockers in heart failure?
    Cleland JG; Loh H; Windram J
    Heart Fail Clin; 2005 Apr; 1(1):57-66. PubMed ID: 17386834
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-blocker therapy for heart failure: the evidence is in, now the work begins.
    Califf RM; O'Connor CM
    JAMA; 2000 Mar; 283(10):1335-7. PubMed ID: 10714735
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
    Goldstein S; Gottlieb SS
    J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.